BGM Stock Summary and Trading Ideas (BGM Group Ltd. - Class A | NASDAQ:BGM)

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

BGM Group Ltd. - Class A trades on the NASDAQ stock market under the symbol BGM.

As of July 31, 2026, BGM stock price climbed to $0.28 with 45,412 million shares trading.

BGM has a beta of 2.40, meaning it tends to be more sensitive to market movements. BGM has a correlation of 0.04 to the broad based SPY ETF.

BGM has a market cap of $112.98 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that BGM belongs to (by Net Assets): ONEQ.

BGM has underperformed the market in the last year with a price return of -96.7% while the SPY ETF gained +19.4%. BGM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.8% and +0.1%, respectively, while the SPY returned +4.2% and +0.5%, respectively.

BGM support price is $.25 and resistance is $.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BGM shares will trade within this expected range on the day.